CARDIO DIAGNOSTICS HOLDINGS (CDIO) Fundamental Analysis & Valuation

NASDAQ:CDIO • US14159C2026

Current stock price

2.29 USD
-0.17 (-6.91%)
At close:
2.4 USD
+0.11 (+4.8%)
Pre-Market:

This CDIO fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. CDIO Profitability Analysis

1.1 Basic Checks

  • CDIO had negative earnings in the past year.
  • In the past year CDIO has reported a negative cash flow from operations.
  • CDIO had negative earnings in each of the past 5 years.
  • CDIO had a negative operating cash flow in each of the past 5 years.
CDIO Yearly Net Income VS EBIT VS OCF VS FCFCDIO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 0 -2M -4M -6M -8M

1.2 Ratios

  • The Return On Assets of CDIO (-83.67%) is worse than 68.98% of its industry peers.
  • With a Return On Equity value of -93.19%, CDIO perfoms like the industry average, outperforming 46.63% of the companies in the same industry.
Industry RankSector Rank
ROA -83.67%
ROE -93.19%
ROIC N/A
ROA(3y)-116.79%
ROA(5y)-96.26%
ROE(3y)-154.69%
ROE(5y)-126.08%
ROIC(3y)N/A
ROIC(5y)N/A
CDIO Yearly ROA, ROE, ROICCDIO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 -200 -400 -600 -800 -1K

1.3 Margins

  • CDIO does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CDIO Yearly Profit, Operating, Gross MarginsCDIO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025 -10K -20K -30K -40K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. CDIO Health Analysis

2.1 Basic Checks

  • CDIO does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for CDIO has been increased compared to 1 year ago.
  • Compared to 5 years ago, CDIO has more shares outstanding
  • Compared to 1 year ago, CDIO has a worse debt to assets ratio.
CDIO Yearly Shares OutstandingCDIO Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 500K 1M 1.5M
CDIO Yearly Total Debt VS Total AssetsCDIO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M

2.2 Solvency

  • Based on the Altman-Z score of -2.08, we must say that CDIO is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -2.08, CDIO is in line with its industry, outperforming 49.71% of the companies in the same industry.
  • A Debt/Equity ratio of 0.04 indicates that CDIO is not too dependend on debt financing.
  • The Debt to Equity ratio of CDIO (0.04) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Altman-Z -2.08
ROIC/WACCN/A
WACC9.23%
CDIO Yearly LT Debt VS Equity VS FCFCDIO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 0 5M -5M

2.3 Liquidity

  • CDIO has a Current Ratio of 9.79. This indicates that CDIO is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of CDIO (9.79) is better than 79.58% of its industry peers.
  • CDIO has a Quick Ratio of 9.79. This indicates that CDIO is financially healthy and has no problem in meeting its short term obligations.
  • CDIO has a Quick ratio of 9.79. This is in the better half of the industry: CDIO outperforms 79.77% of its industry peers.
Industry RankSector Rank
Current Ratio 9.79
Quick Ratio 9.79
CDIO Yearly Current Assets VS Current LiabilitesCDIO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. CDIO Growth Analysis

3.1 Past

  • CDIO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 64.63%, which is quite impressive.
  • CDIO shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -57.31%.
EPS 1Y (TTM)64.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%30.66%
Revenue 1Y (TTM)-57.31%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-28%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4661.9%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CDIO Yearly Revenue VS EstimatesCDIO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 5M 10M 15M 20M 25M
CDIO Yearly EPS VS EstimatesCDIO Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 -5 -10 -15 -20 -25

More info and screens

Find the best growth stocksShow best growing peers

0

4. CDIO Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for CDIO. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CDIO Price Earnings VS Forward Price EarningsCDIO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CDIO Per share dataCDIO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CDIO Dividend Analysis

5.1 Amount

  • No dividends for CDIO!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CDIO Fundamentals: All Metrics, Ratios and Statistics

CARDIO DIAGNOSTICS HOLDINGS

NASDAQ:CDIO (3/20/2026, 8:00:03 PM)

Premarket: 2.4 +0.11 (+4.8%)

2.29

-0.17 (-6.91%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-18
Earnings (Next)05-13
Inst Owners7.09%
Inst Owner Change13.88%
Ins Owners3.9%
Ins Owner Change0%
Market Cap6.78M
Revenue(TTM)14.90K
Net Income(TTM)-6.50M
Analysts82.86
Price TargetN/A
Short Float %30.05%
Short Ratio0.1
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-98.35%
Min Revenue beat(2)-98.59%
Max Revenue beat(2)-98.1%
Revenue beat(4)1
Avg Revenue beat(4)364.06%
Min Revenue beat(4)-98.59%
Max Revenue beat(4)1743.14%
Revenue beat(8)1
Avg Revenue beat(8)140.01%
Revenue beat(12)1
Avg Revenue beat(12)61.11%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 454.93
P/FCF N/A
P/OCF N/A
P/B 0.97
P/tB 1.11
EV/EBITDA N/A
EPS(TTM)-3.72
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-2.08
FCFYN/A
OCF(TTM)-1.93
OCFYN/A
SpS0.01
BVpS2.36
TBVpS2.06
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -83.67%
ROE -93.19%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-116.79%
ROA(5y)-96.26%
ROE(3y)-154.69%
ROE(5y)-126.08%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 105.33%
Cap/Sales 2814.09%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 9.79
Quick Ratio 9.79
Altman-Z -2.08
F-Score2
WACC9.23%
ROIC/WACCN/A
Cap/Depr(3y)321.1%
Cap/Depr(5y)382.66%
Cap/Sales(3y)2878.77%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)64.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%30.66%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-57.31%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-28%
Revenue Next Year4661.9%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y22.54%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-13.87%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-14.69%
OCF growth 3YN/A
OCF growth 5YN/A

CARDIO DIAGNOSTICS HOLDINGS / CDIO Fundamental Analysis FAQ

What is the fundamental rating for CDIO stock?

ChartMill assigns a fundamental rating of 1 / 10 to CDIO.


What is the valuation status for CDIO stock?

ChartMill assigns a valuation rating of 0 / 10 to CARDIO DIAGNOSTICS HOLDINGS (CDIO). This can be considered as Overvalued.


How profitable is CARDIO DIAGNOSTICS HOLDINGS (CDIO) stock?

CARDIO DIAGNOSTICS HOLDINGS (CDIO) has a profitability rating of 0 / 10.